Диссертация (1139673), страница 40
Текст из файла (страница 40)
Ruleetal. // Am. J. Transplant. — 2013. — Vol.13, № 3. — P. 676-684.84.Armstrong G.L. The prevalence of hepatitis C virus infection in the UnitedStates, 1999 through 2002 / G.L. Armstrong, A. Wasley, E.P. Simard, G.M. McQuillanet al. // Ann Intern Med. — 2006. — Vol. 144, №10. — P. 705— 714.85.Arnol M. Association of Pretransplant Renal Replacement Therapy DurationWith Outcome in Kidney Transplant Recipients: A Prevalent Cohort Study in Slovenia /M.
Arnol, J. Buturović-Ponikvar, A. Kandus //Therapeutic Apheresis and Dialysis.DOI: 10.1111/j.1744-9987.2011.00943.x.86.Ashry A. Dilemma of HCV infection in renal transplant recipients. / A.Ashry // Int J Nephrol. — 2011. — 471214.87.Astor B. Serum β2-Microglobulin at discharge predicts mortality and graftloss following kidney transplantation / B.
Astor, B. Muth, D. Kaurmanet al. // Kidney Int.— 2013. — Vol.84. — P. 810-817.29288.Auerbach O. Smoking in relation to atherosclerosis of the coronary arteries/ O. Auerbach, E.C. Hammond, L. Garfinkel //N. Engl. J. Med. — 1965. — Vol. 273. —P. 775-779.89.Bagshaw S.M. A comparison of the RIFLE and AKIN criteria for acutekidney injury in critically ill patients / S.M.
Bagshaw, C. George, R. Bellomo //Nephrology Dialysis Transplantation. — 2008. — Vol. 23, № 5. — P. 1569-1574.90.Bagshaw S.M. Early acute kidney injury and sepsis: a multicentre evaluation/ S.M. Bagshaw, C. George, R. Bellomo // Critical Care. — 2008. — Vol. 12, №2. — P.47.91.Bianchi C. Reappraisal of serum beta2-microglobulin as marker of GFR / C.Bianchi, C.Donadio, G. Tramonti et al. // Ren. Fail. — 2001. — Vol.23. — P. 419.92.Bittar J.
Renal transplantation in diabetic patients / J. Bittar, P. Cepeda, J.dela Fuente, W. Douthat et al. // Transplant. Proc.— 2006. — Vol.38, №3. — P. 895-898.93.Black H.R. Effect of heavy cigarette smoking on renal and myocardialarterioles / H.R. Black, G.R. Zeevi, R.M. Silten, G.J.W. Smith // Nephron. — 1983. —Vol.34. — P.
173-179.94.Boucek P. Kidney transplantation in type 2 diabetic patients: a comparisonwith matched non-diabetic subjects / P. Boucek, F. Saudek, E. Pokorna, S. Vitko et al.//Nephrol. DialTransplant. — 2002. — Vol.17. — P. 1678-1683.95.Boom H. Delayed graft function influences renal function, but not survival /H. Boom, M.J.K. Mallat, J.W. De Fijter et al. // Kidney International. — 2000.
— Vol.58,№2. — P. 859-866.96.Braun W.E. Transplantation: strength in numbers-predicting long-termtransplant outcomes / W.E. Braun, J.D. Schold // Nat. Rev. Nephrol. — 2011. — Vol.7.— P. 135.97.Brennan D.C. Cytomegalovirus in renal transplantation / D.C. Brennan // J.Am. Soc.Nephrol. — 2001. — Vol. 12. — P. 848-855.98.Briggs J.D.
Causes of death after renal transplantation /J.D. Briggs //Nephrol. Dial. Transplant. — 2001. — Vol. 16, №8.— P. 1545-1549.99.Carden D.L. Pathophysilogy of ischaemia-reperfusion injuri / D.L. Carden,D.N. Granger //J. Pathol. — 2000. — Vol.190, №3. — P. 255-266.293100.Carvalho M.F.S. Hyperlipidemia as a risk factor of renal allograft functionimpairment / M.F.S. Carvalho, V. Soares // Clin. Transplant. — 2001. — Vol.15. — P.48-52.101.Case J.
Epidemiology of acute kidney injury in the intensive care unit / J.Case, S. Khan, R. Khalidet al. // Critical Care Research and Practice.— 2013.— articleID 479730.102.Cecka J.M. Kidney transplantation in the United States / J.M. Cecka // Clin.Transpl. — Los Angeles: UCLA Tissue Typing Laboratory. — 2008. — P. 1-18.103.Centers for Disease Control and Prevention (CDC): Hepatitis C virustransmission at an outpatient hemodialysis unit— New York, 2001-2008 / MMWR MorbMortal Wkly Rep. 2009. 58 (8): Р. 189— 194.104.Chadban S.
Transplantation / S. Chadban, P. Clayton, L. Excell // In S.McDonald, L. Excell, B. Livingstone (Eds.). — Australia, 2010. — P.1-31.105.Charlson M.E. A new method of classifying prognostic comorbidity inlongitudinal studies: development and validation / M.E. Charlson, P. Pompei, K.L. Ales,C.R. MacKenzie // J. Chron. Dis. — 1987.
— Vol. 40, №5. — P. 373-383.106.ChauK.F. Reabilitation of patients with end-stage renal disease/ K.F.Chau,W.L. Chau, M.K.Wong et al. // Medical Section. — 2003. — Vol.8. — Р. 3-13.107.Chisholm-Burns M.A. Immunosuppressant therapy adherence and graftfailure among pediatric renal transplant recipients // M.A. Chisholm-Burns, C.A. Spivey,R. Rehfeld, M.
Zawaideh et al.//Am. J. Transplant. — 2009. — Vol. 9. — P. 2497-2504.108.Cho Y.W. New variables reported to the UNOS registry and their impact oncadaveric renal transplant outcomes — a preliminary study / Y.W. Cho, P.I. Terasaki,J.M. Cecka // Clin. Transpl. — 1995. — P. 405-415.109.Clayton P. ANZDATA Registry 2010 Report. Chapter8.2010. P. Clayton, L.Excell, S. Campbell / ANZDATA Registry 2010 Report. Chapter8.2010 //[Электронныйресурс]Режимдоступа:http://www.anzdata.org.au/anzdata/AnzdataReport/33rdReport/Ch08.pdf110.Cohen D. General health management and long-term care of the renaltransplant recipient / D. Cohen, C.
Galbraith / Am. J. Kidney Dis. — 2001. — Vol.38. —P. 10-24.294111.CollaborativeTransplantStudy/[Электронныйресурс].—Режимдоступа:http://www.ctstransplant.org/112.Coupel S. Ten-year survival of second kidney transplants: impact ofimmunologic factors and renal function at 12 months / S. Coupel, M. Giral-Classe, G.Karam, J.F. Morcet et al. // Kidney Int.
— 2003. — Vol. 64, №2. — P.674.113.Couser W.G. The contribution of chronic kidney disease to the global burdenof major noncommunicable diseases / W.G.Couser, G.Remuzzi, S.Mendis, M.Tonelli //Kidney International. — 2011. — Vol. 80. — P. 1258-1280.114.Danovitch G.M. Allocation of deceased donor kidneys: past, present, andfuture / G.M. Danovitch, J.M. Cecka // Am.
J. Kidney Dis. — 2003. — Vol. 42, №5. —P. 882-890.115.Denhaerynck K. Prevalence and risk factors of non-adherence withimmunosuppressive medication in kidney transplant patients / K. Denhaerynck, J. Steiger,A. Bock, P. Schafer-Keller // Am. J. Transplant. — 2007.
— Vol.7. — P. 108-116.116.DenhaerynckK.Prevalence,consequences,anddeterminantsofnonadherence in adult renal transplant patients: A literature review / K. Denhaerynck, F.Dobbels, I. Cleemput, A. Desmyttere // Transpl. Int. — 2005. — Vol.18. — P. 11211133.117.Dew M.A. Does transplantation produce quality of life benefits? Aquantitative analysis of the literature / M.A. Dew, G.E. Switzer, J.M.
Goycoolea //Transplantation.— 1997.— Vol. 64.— P.1261.118.Didlake R.H. Patient noncompliance: A major cause of late graft failure incyclosporine-treated renal transplants / R.H. Didlake, K. Dreyfus, R.H. Kerman, C.T. VanBuren et al. // Transplant. Proc. — 1988. — Vol.20. — P. 63-69.119.Dieterle F. Urinary clusterin, cystatin C, beta2-microglobulin and totalprotein as markers to detect drug-induced kidney injury/ F.Dieterle, E.Perentes, A.Cordier et al.
/Nat. Biotechnol.— 2010. — Vol. 28. — P.463.120.Ditonno P. Effects of ischemia-reperfusion injury in Kidney Transplantation:risk factors and early and long-term outcomes in a single center / P. Ditonno, S.V.Impedovo, S. Palazzo, C. Bettocchi // Transplant. Proc. — 2013. — Vol. 45, №7. — P.2641-2644.295121.DoyleS.E. Predicting clinical outcome in the elderly renal transplantrecipient / S.E.Doyle, A.J.Matas, K.Gillinghamet al.
//Kidney International.— 2000.—Vol.57. — P. 1523-1755.122.Drawz P.E. Predicting hospital-acquired acute kidney injury — acase-controlled study / P.E. Drawz, R.T. Miller, A.R. Sehgal // Renal Failure. — 2008. —Vol.30, №9. — P.848-855.123.Dunn T.B. Revisiting traditional risk factors for rejection and graft loss afterkidney transplantation // T.B.
Dunn, H. Noreen, K. Gillinghamet al. // Am. J.Transp. —2011. — Vol. 11, №10. — P. 2132-2143.124.EI-Agroudy A.E. Characteristics of recipients whose kidney allograft hasfunctioned for more than 20 years / A.E. EI-Agroudy, K. EI-Dahshan, T.M. Abbas, A.M.Ismail et al.// Exp. Clin.Transpl. — 2008. — Vol. 6, № 2. — P. 155-160.125.Emiroglu R. Role of donor age and acute rejection episodes on long-termgraft survival in cadaveric kidney transplantation / R.
Emiroglu, M.C. Yagmurdur,F.Karakayali et al. // Transplant. Proc.— 2005. — Vol.37, №7. — P. 2954-2956.126.Evans R.W. An economic analysis of kidney transplantation. / R.W. Evans,D. Kitzmann // Surg. Clin. North. Am.— 1998.— Vol. 78.— P.149-174.127.Evans R.W. The quality of life of patients with end-stage renal disease / R.W.Evans, D.L Manninen, Jr. Garrison // New England J.
Med. — 1985. — Vol. 312, №9.— P. 553-559.128.Fabrizi F. HBsAg seropositive status and survival after renal transplantation:Meta-analysis of observational studies. F. Fabrizi, P. Martin, V. Dixit, F. Kanwal, G.Dulai / Am J Transplant // 2005. — Vol. 5. — P. 2913— 2921.129.Fabrizi F.
Hepatitis C virus infection and post-transplant diabetes mellitusamong renal transplant patients: A meta-analysis / F. Fabrizi, P. Messa, P. Martin, B.Takkouche // Int J Artif Organs. — 2008. — №31. — P. 675— 682.130.Faravardeh A. Predictors of graft failure and death in elderly kidneytransplant recipients / A.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
